News

COVID-19 Trial Participants at the University of Emory Report Positive Results

Written by Yourway | July 23, 2020

Healthy volunteers at the University of Emory reported positive results in the phase II trial for a COVID-19 vaccine developed by Moderna in collaboration with the University of Cambridge. The vaccine produced a robust immune response and was well-tolerated with minimal side effects observed. With headquarters in the U.S., Yourway delivers full trial support and can easily access trial sites across the country.